Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed on April 23, 2018, by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares. The report covers the month of April 2018 and serves to furnish specific corporate announcements to the U.S. Securities and Exchange Commission.
Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover sheet for attached exhibits rather than a financial statement.
Material Changes
No material financial changes or comparative period data are detailed within the body of this Form 6-K. The filing references two attached exhibits issued on April 21, 2018:
- Exhibit 99.1: A press release.
- Exhibit 99.2: An ad-hoc announcement pursuant to Article 17(1) of the Market Abuse Regulation (MAR).
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. Investors must refer to the attached press release and ad-hoc announcement for details on the events triggering this filing.
Key Facts for Investor Verification
- Verify the content of the April 21, 2018, press release (Exhibit 99.1) to understand the nature of the corporate announcement.
- Review the ad-hoc announcement (Exhibit 99.2) for regulatory disclosures required under EU Market Abuse Regulation.
- Note that this filing does not contain standalone financial performance data.